Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.
J
J
Minami
E
E
Ohno
S
S
Furukata
T
T
Ishimitsu
H
H
Matsuoka
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects*; D018660:Blood Pressure Monitoring, Ambulatory; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D007564:Japan; D011237:Predictive Value of Tests; D011446:Prospective Studies; D011863:Radioimmunoassay; D012083:Renin / Q000097:blood*; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D015415:Biomarkers; D013777:Tetrazoles; D000068756:Valsartan; D012083:Renin; D014633:Valine